ID

14464

Description

Positive Expiratory Pressure for the Treatment of Acute Asthma in Children; ODM derived from: https://clinicaltrials.gov/show/NCT02494076

Lien

https://clinicaltrials.gov/show/NCT02494076

Mots-clés

Versions (1)
  1. 17/04/2016 17/04/2016 -
Téléchargé le

17 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Asthma NCT02494076

Anglais

Eligibility Asthma NCT02494076

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT02494076
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age >= 2 and < 18 years of age
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
established diagnosis of asthma, defined as at least two prior episodes of treatment with bronchodilators in their lifetime
Description

Asthma | Bronchodilator Agents Therapeutic procedure

Type de données

boolean

Alias
UMLS CUI [1]
C0004096
UMLS CUI [2,1]
C0006280
UMLS CUI [2,2]
C0087111
initial ed presentation with a moderate to severe asthma exacerbation, as defined by a pulmonary asthma score (pas) >7
Description

Exacerbation of moderate persistent asthma | Exacerbation of severe persistent asthma | Pulmonary Asthma Score

Type de données

boolean

Alias
UMLS CUI [1]
C3873345
UMLS CUI [2]
C3508930
UMLS CUI [3,1]
C2709248
UMLS CUI [3,2]
C0004096
UMLS CUI [3,3]
C0449820
pas score >7 and <12 after completion of first line therapies (three doses albuterol/ipratropium bromide and oral corticosteroids)
Description

Pulmonary Asthma Score | First line treatment | Albuterol | Ipratropium Bromide | Adrenal Cortex Hormones

Type de données

boolean

Alias
UMLS CUI [1,1]
C2709248
UMLS CUI [1,2]
C0004096
UMLS CUI [1,3]
C0449820
UMLS CUI [2]
C1708063
UMLS CUI [3]
C0001927
UMLS CUI [4]
C0700580
UMLS CUI [5]
C0001617
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
do not receive complete first line therapies
Description

First line treatment

Type de données

boolean

Alias
UMLS CUI [1]
C1708063
immediately receive a disposition (admission or discharge) as determined by the treating clinician after completion of first line therapies
Description

Patient Admission | Discharge status | First line treatment

Type de données

boolean

Alias
UMLS CUI [1]
C0030673
UMLS CUI [2]
C0586514
UMLS CUI [3]
C1708063
receive prednisone or more than two doses of inhaled bronchodilators prior to main ed evaluation (e.g. during ems transport or primary care visit)
Description

Prednisone | Inhaled bronchodilator therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0032952
UMLS CUI [2]
C0578554
co-morbid illnesses interfering with or contraindicated to usual asthma therapy (e.g. facial or airway abnormalities, pneumonia, chronic lung disease, congenital heart disease, cystic fibrosis, or pneumothorax)
Description

Comorbidity | Medical contraindication Therapeutic procedure Asthma | Face Abnormality | Airway abnormalities | History of chronic lung disease | Congenital heart disease | Cystic Fibrosis | Pneumothorax

Type de données

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C0004096
UMLS CUI [3,1]
C0015450
UMLS CUI [3,2]
C1704258
UMLS CUI [4]
C4012443
UMLS CUI [5]
C1533075
UMLS CUI [6]
C0152021
UMLS CUI [7]
C0010674
UMLS CUI [8]
C0032326
critically ill at presentation
Description

Critical Illness

Type de données

boolean

Alias
UMLS CUI [1]
C0010340
pregnant women (women known to be pregnant at the time of enrollment)
Description

Pregnancy

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
Retour au début de la page

Similar models

Eligibility Asthma NCT02494076

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT02494076
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age >= 2 and < 18 years of age
boolean
C0001779 (UMLS CUI [1])
Asthma | Bronchodilator Agents Therapeutic procedure
Item
established diagnosis of asthma, defined as at least two prior episodes of treatment with bronchodilators in their lifetime
boolean
C0004096 (UMLS CUI [1])
C0006280 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
Exacerbation of moderate persistent asthma | Exacerbation of severe persistent asthma | Pulmonary Asthma Score
Item
initial ed presentation with a moderate to severe asthma exacerbation, as defined by a pulmonary asthma score (pas) >7
boolean
C3873345 (UMLS CUI [1])
C3508930 (UMLS CUI [2])
C2709248 (UMLS CUI [3,1])
C0004096 (UMLS CUI [3,2])
C0449820 (UMLS CUI [3,3])
Pulmonary Asthma Score | First line treatment | Albuterol | Ipratropium Bromide | Adrenal Cortex Hormones
Item
pas score >7 and <12 after completion of first line therapies (three doses albuterol/ipratropium bromide and oral corticosteroids)
boolean
C2709248 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0449820 (UMLS CUI [1,3])
C1708063 (UMLS CUI [2])
C0001927 (UMLS CUI [3])
C0700580 (UMLS CUI [4])
C0001617 (UMLS CUI [5])
Item Group
C0680251 (UMLS CUI)
First line treatment
Item
do not receive complete first line therapies
boolean
C1708063 (UMLS CUI [1])
Patient Admission | Discharge status | First line treatment
Item
immediately receive a disposition (admission or discharge) as determined by the treating clinician after completion of first line therapies
boolean
C0030673 (UMLS CUI [1])
C0586514 (UMLS CUI [2])
C1708063 (UMLS CUI [3])
Prednisone | Inhaled bronchodilator therapy
Item
receive prednisone or more than two doses of inhaled bronchodilators prior to main ed evaluation (e.g. during ems transport or primary care visit)
boolean
C0032952 (UMLS CUI [1])
C0578554 (UMLS CUI [2])
Comorbidity | Medical contraindication Therapeutic procedure Asthma | Face Abnormality | Airway abnormalities | History of chronic lung disease | Congenital heart disease | Cystic Fibrosis | Pneumothorax
Item
co-morbid illnesses interfering with or contraindicated to usual asthma therapy (e.g. facial or airway abnormalities, pneumonia, chronic lung disease, congenital heart disease, cystic fibrosis, or pneumothorax)
boolean
C0009488 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0004096 (UMLS CUI [2,3])
C0015450 (UMLS CUI [3,1])
C1704258 (UMLS CUI [3,2])
C4012443 (UMLS CUI [4])
C1533075 (UMLS CUI [5])
C0152021 (UMLS CUI [6])
C0010674 (UMLS CUI [7])
C0032326 (UMLS CUI [8])
Critical Illness
Item
critically ill at presentation
boolean
C0010340 (UMLS CUI [1])
Pregnancy
Item
pregnant women (women known to be pregnant at the time of enrollment)
boolean
C0032961 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial